Park Avenue Securities’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.38M | Sell |
10,885
-272
| -2% | -$59.5K | 0.02% | 462 |
|
|
2025
Q1 | $2.5M | Buy |
11,157
+2,440
| +28% | +$546K | 0.03% | 344 |
|
|
2024
Q4 | $2.86M | Buy |
8,717
+1,222
| +16% | +$400K | 0.03% | 362 |
|
|
2024
Q3 | $2.25M | Sell |
7,495
-654
| -8% | -$196K | 0.03% | 402 |
|
|
2024
Q2 | $2.68M | Buy |
8,149
+466
| +6% | +$153K | 0.03% | 334 |
|
|
2024
Q1 | $3.04M | Buy |
7,683
+291
| +4% | +$115K | 0.04% | 293 |
|
|
2023
Q4 | $2.6M | Sell |
7,392
-154
| -2% | -$54.2K | 0.04% | 305 |
|
|
2023
Q3 | $2.83M | Buy |
+7,546
| New | +$2.83M | 0.04% | 247 |
|
|
2023
Q1 | – | Sell |
-7,739
| Closed | -$1.82M | – | 1173 |
|
|
2022
Q4 | $1.82M | Sell |
7,739
-1,085
| -12% | -$255K | 0.03% | 333 |
|
|
2022
Q3 | $2.17M | Sell |
8,824
-1,500
| -15% | -$369K | 0.04% | 249 |
|
|
2022
Q2 | $3.12M | Sell |
10,324
-900
| -8% | -$272K | 0.06% | 192 |
|
|
2022
Q1 | $4.61M | Buy |
11,224
+548
| +5% | +$225K | 0.08% | 136 |
|
|
2021
Q4 | $5.01M | Buy |
10,676
+1,085
| +11% | +$509K | 0.09% | 126 |
|
|
2021
Q3 | $4.07M | Sell |
9,591
-323
| -3% | -$137K | 0.08% | 122 |
|
|
2021
Q2 | $3.56M | Buy |
9,914
+1,865
| +23% | +$670K | 0.08% | 138 |
|
|
2021
Q1 | $2.27M | Buy |
8,049
+1,457
| +22% | +$411K | 0.06% | 181 |
|
|
2020
Q4 | $1.87M | Buy |
6,592
+920
| +16% | +$261K | 0.05% | 167 |
|
|
2020
Q3 | $1.56M | Buy |
5,672
+863
| +18% | +$237K | 0.05% | 159 |
|
|
2020
Q2 | $1.09M | Buy |
+4,809
| New | +$1.09M | 0.04% | 182 |
|
|
2020
Q1 | – | Sell |
-2,622
| Closed | -$394K | – | 622 |
|
|
2019
Q4 | $394K | Sell |
2,622
-49
| -2% | -$7.36K | 0.02% | 394 |
|
|
2019
Q3 | $379K | Buy |
+2,671
| New | +$379K | 0.02% | 305 |
|
|
2019
Q2 | – | Sell |
-2,195
| Closed | -$245K | – | 485 |
|
|
2019
Q1 | $245K | Buy |
+2,195
| New | +$245K | 0.01% | 382 |
|